Consolidated Statement Of Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7604217

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Consolidated statement of income
Statement of income
Net sales
51,082,000,000 JPY
51,081,000,000 JPY
30,085,000,000 JPY
30,085,000,000 JPY
Cost of sales
10,461,000,000 JPY
10,463,000,000 JPY
7,812,000,000 JPY
7,815,000,000 JPY
Operating expenses
Operating expenses - general
Depreciation
92,000,000 JPY
103,000,000 JPY
Operating expenses
Selling, general and administrative expenses
20,686,000,000 JPY
20,480,000,000 JPY
14,003,000,000 JPY
13,627,000,000 JPY
Operating expenses
Ordinary profit (loss)
20,512,000,000 JPY
20,425,000,000 JPY
8,488,000,000 JPY
8,594,000,000 JPY
Net sales
Gross profit (loss)
40,620,000,000 JPY
40,618,000,000 JPY
22,272,000,000 JPY
22,269,000,000 JPY
Operating profit (loss)
19,933,000,000 JPY
20,137,000,000 JPY
8,269,000,000 JPY
8,641,000,000 JPY
Operating expenses
Research and development expenses
7,175,000,000 JPY
7,373,000,000 JPY
5,360,000,000 JPY
5,353,000,000 JPY
General and administrative expenses
Non-operating income
Dividend income
28,000,000 JPY
28,000,000 JPY
25,000,000 JPY
25,000,000 JPY
Interest income
7,000,000 JPY
1,000,000 JPY
7,000,000 JPY
1,000,000 JPY
Interest on securities
4,000,000 JPY
2,000,000 JPY
Other
68,000,000 JPY
70,000,000 JPY
65,000,000 JPY
70,000,000 JPY
Non-operating income
656,000,000 JPY
641,000,000 JPY
305,000,000 JPY
309,000,000 JPY
Extraordinary income
0 JPY
0 JPY
170,000,000 JPY
236,000,000 JPY
Selling, general and administrative expenses
Cost of sales
Extraordinary losses
1,108,000,000 JPY
1,108,000,000 JPY
5,000,000 JPY
5,000,000 JPY
Loss on disposal of non-current assets
2,000,000 JPY
2,000,000 JPY
5,000,000 JPY
5,000,000 JPY
Other
105,000,000 JPY
105,000,000 JPY
JPY
JPY
Non-operating expenses
77,000,000 JPY
353,000,000 JPY
85,000,000 JPY
356,000,000 JPY
Interest expenses
45,000,000 JPY
44,000,000 JPY
42,000,000 JPY
41,000,000 JPY
Non-operating expenses
Other
18,000,000 JPY
20,000,000 JPY
31,000,000 JPY
26,000,000 JPY
Profit (loss) before income taxes
19,404,000,000 JPY
19,317,000,000 JPY
8,653,000,000 JPY
8,825,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
0 JPY
0 JPY
JPY
JPY
Income taxes - current
5,549,000,000 JPY
5,531,000,000 JPY
2,836,000,000 JPY
2,818,000,000 JPY
Extraordinary losses
Income taxes - deferred
-663,000,000 JPY
-661,000,000 JPY
-1,072,000,000 JPY
-1,074,000,000 JPY
Income taxes
4,886,000,000 JPY
4,870,000,000 JPY
1,764,000,000 JPY
1,743,000,000 JPY
Profit (loss)
14,446,000,000 JPY
14,446,000,000 JPY
14,446,000,000 JPY
14,517,000,000 JPY
14,446,000,000 JPY
7,081,000,000 JPY
7,081,000,000 JPY
6,888,000,000 JPY
7,081,000,000 JPY
7,081,000,000 JPY
Profit (loss) attributable to non-controlling interests
10,000,000 JPY
-4,000,000 JPY
Profit (loss) attributable to owners of parent
14,507,000,000 JPY
14,507,000,000 JPY
14,507,000,000 JPY
6,892,000,000 JPY
6,892,000,000 JPY
6,892,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
-71,000,000 JPY
107,000,000 JPY
Deferred gains or losses on hedges
0 JPY
0 JPY
Foreign currency translation adjustment
68,000,000 JPY
-162,000,000 JPY
Remeasurements of defined benefit plans, net of tax
0 JPY
7,000,000 JPY
Other comprehensive income
-3,000,000 JPY
-47,000,000 JPY
Comprehensive income
14,514,000,000 JPY
6,841,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
14,483,000,000 JPY
6,855,000,000 JPY
Comprehensive income attributable to non-controlling interests
31,000,000 JPY
-14,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.